Sponsor

Phenomix

Clinical research sponsor

Published trials11
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

11 shown
Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of MetforminNCT00998686 · lead sponsor · 2009-11-01
TERMINATED
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal ImpairmentNCT00958269 · lead sponsor · 2009-08-01
TERMINATED
Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of MetforminNCT00850239 · lead sponsor · 2009-05-01
TERMINATED
Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes MellitusNCT00865592 · lead sponsor · 2009-03-01
TERMINATED
Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes MellitusNCT00690638 · lead sponsor · 2008-07-01
COMPLETED
Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes MellitusNCT01101945 · lead sponsor · 2007-07-01
TERMINATED
A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes MellitusNCT00482950 · lead sponsor · 2007-04-01
UNKNOWN
Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes MellitusNCT00530881 · lead sponsor · 2006-04-01
COMPLETED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneNCT01089790 · collaborator · 2010-03-01
TERMINATED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With PioglitazoneNCT00970424 · collaborator · 2009-08-01
TERMINATED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without MetforminNCT00947557 · collaborator · 2009-07-01
TERMINATED

Sponsor roles

lead sponsor8
collaborator3

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.